GO:0003711 transcription elongation factor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003711 transcription elongation factor activity describes a molecular function that stimulates the elongation properties of RNA polymerase during the elongation phase of transcription.
• Transcription elongation factors include processive antitermination factors that help RNA polymerase read through termination signals.
• Some elongation factors, such as ELOF1, couple transcription elongation to DNA repair by directing RNA polymerase II ubiquitylation.
• Disruption of elongation factor activity is linked to human disease, including developmental disorders and cancer.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of elongation factor genes.
• EDITGENE provides end-to-end CRISPR cell model and library screening services for transcription elongation factor research.
Description
Transcription elongation factor activity (GO:0003711) is a molecular function that stimulates the elongation properties of RNA polymerase during the elongation phase of transcription. This activity is essential for efficient RNA synthesis and for coupling transcription to downstream processes such as DNA repair and RNA processing. Elongation factors can act by enabling the transition from transcription initiation to elongation or by rescuing stalled RNA polymerases. The importance of this function is underscored by its conservation across all domains of life and by the growing list of human diseases associated with mutations in elongation factor genes. Researchers studying gene regulation, cancer, and developmental disorders increasingly focus on elongation factors as potential therapeutic targets. Understanding the molecular mechanisms, key genes, and experimental models for GO:0003711 is therefore critical for both basic and translational research.
transcription elongation factor activity At A Glance
| GO ID | GO:0003711 |
|---|---|
| GO term | transcription elongation factor activity |
| Ontology | molecular_function |
| Synonym | transcriptional elongation regulator activity; transcription elongation regulator activity |
| Major function | Stimulates the elongation properties of RNA polymerase during the elongation phase of transcription |
| Subclasses | Factors enabling initiation-to-elongation transition; factors rescuing stalled RNA polymerases |
| Related processes | Transcription elongation, DNA repair, RNA processing |
| Disease relevance | Cancer, developmental disorders, neurodegeneration |
What Is GO:0003711?
In simple terms, transcription elongation factor activity is the function of proteins that help RNA polymerase keep moving along DNA during the elongation phase of transcription. According to the QuickGO definition, it is a molecular function that stimulates the elongation properties of RNA polymerase during elongation. A subclass of transcription elongation factors enables the transition from transcription initiation to elongation, while another class rescues stalled RNA polymerases. This activity is distinct from initiation and termination factors, although some factors may have overlapping roles.
Why Is transcription elongation factor activity Important in Cell Biology?
Transcription elongation factor activity is important because it controls the rate and processivity of RNA synthesis, which directly impacts gene expression programs. Dysregulation of elongation factors can lead to widespread transcriptional defects and has been implicated in human diseases such as cancer and developmental syndromes. Moreover, elongation factors often serve as integration hubs for cellular signals, linking transcription to DNA repair, cell cycle progression, and stress responses. Understanding GO:0003711 is therefore essential for deciphering mechanisms of gene regulation and for identifying therapeutic targets.
• Controls the speed and processivity of RNA polymerase during transcription elongation.
• Enables the transition from transcription initiation to elongation.
• Rescues stalled RNA polymerases at DNA lesions or other obstacles.
• Couples transcription elongation to DNA repair pathways.
• Mutations in elongation factor genes are associated with human developmental disorders.
• Elongation factors are often deregulated in cancer.
• Provides targets for therapeutic intervention in transcriptional diseases.
• Essential for proper gene expression in response to cellular stress.
What Happens During transcription elongation factor activity?
Initiation-to-elongation transition
In simple terms: This is the step where RNA polymerase switches from starting transcription to actively moving along the DNA.
A subclass of transcription elongation factors enables the transition from transcription initiation to elongation by modifying RNA polymerase or its associated factors. These factors help overcome promoter-proximal pausing and promote processive elongation.
Processive antitermination
In simple terms: Some elongation factors help RNA polymerase ignore stop signals so it can continue transcribing long genes.
Processive antitermination factors allow RNA polymerase to read through termination signals, ensuring complete synthesis of long transcripts. This mechanism is critical for the expression of large genes and operons.
Rescue of stalled RNA polymerases
In simple terms: When RNA polymerase gets stuck, specialized factors help it restart transcription.
Another class of elongation factors rescues stalled RNA polymerases, for example at DNA lesions. ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation to facilitate rescue.
Coupling to DNA repair
In simple terms: Elongation factors can also signal DNA damage to the repair machinery.
Transcription elongation factors such as ELOF1 couple transcription to DNA repair by recruiting ubiquitin ligases to RNA polymerase II. This ensures that transcription-blocking lesions are repaired efficiently.
Key Genes Involved in GO:0003711 transcription elongation factor activity
The following genes encode proteins with transcription elongation factor activity or directly regulate this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ELOF1 | Transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation | Knockout studies reveal defects in transcription-coupled repair |
| TFIIS | Rescues stalled RNA polymerase II by stimulating cleavage of nascent RNA | Point mutations affect elongation and stress responses |
| SPT5 | Processive antitermination and elongation regulation | Knockdown impairs transcription of long genes |
| SPT4 | Forms complex with SPT5 to regulate elongation | Mutations linked to developmental disorders |
| ELL | Enables transition from initiation to elongation | Overexpression associated with leukemia |
| ELL2 | Elongation factor that promotes processive transcription | Knockout affects immunoglobulin secretion |
| EAF1 | Component of the ELL complex | Regulates elongation and cell cycle |
| EAF2 | Component of the ELL complex | Tumor suppressor candidate |
| CDK9 | Kinase that phosphorylates RNA polymerase II to promote elongation | Inhibitors used in cancer therapy |
| Cyclin T1 | Regulatory subunit of CDK9 | Knockout blocks elongation |
| BRD4 | Recruits CDK9 to chromatin | Target of BET inhibitors |
| AFF4 | Scaffold protein in super elongation complex | Mutations linked to developmental disorders |
| AFF1 | Component of super elongation complex | Translocation associated with leukemia |
| ENL | Reader of histone acetylation that promotes elongation | Knockout impairs transcription |
| AF9 | Component of super elongation complex | Fusion protein in leukemia |
| MIEF1 | Mitochondrial mechanotransduction factor that coordinates nuclear response | Links mechanotransduction to transcription |
| eEF1A1 | Translation elongation factor with additional nuclear roles | Disruption affects macrophage glycolytic reprogramming |
How Is transcription elongation factor activity Regulated?
Transcription elongation factor activity is regulated at multiple levels, including post-translational modifications of RNA polymerase II and its associated factors. Phosphorylation of the RNA polymerase II C-terminal domain by CDK9 is a key regulatory step that promotes elongation. Additionally, ubiquitination and other modifications of elongation factors can control their stability and interactions. Cellular signals such as mechanical forces can also influence elongation through mechanotransduction pathways involving MIEF1.
transcription elongation factor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ELOF1 | Transcription-coupled DNA repair deficiency | Knockout cell lines |
| AFF1 | Leukemia | Knock-in of fusion protein |
| CDK9 | Cancer | Point mutation of kinase domain |
| SPT4 | Developmental disorder | Knockout zebrafish |
| MIEF1 | Metastatic chemotherapy resistance | Overexpression in cancer cells |
Cancer
Dysregulation of transcription elongation factors is frequently observed in cancer. For example, the super elongation complex, including AFF1 and AF9, is involved in leukemogenic translocations. CDK9 inhibitors are being explored as anticancer agents.
Developmental disorders
Mutations in elongation factor genes such as SPT4 and AFF4 have been linked to developmental disorders characterized by intellectual disability and craniofacial abnormalities.
Neurodegeneration
Defects in transcription elongation and coupled DNA repair can lead to neurodegeneration, as seen in disorders like Cockayne syndrome.
From transcription elongation factor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ELOF1 impair transcription-coupled repair? | ELOF1 knockout cell line |
| Does a point mutation in CDK9 affect elongation? | CDK9 point mutation knock-in |
| Can overexpression of ELL drive leukemia? | ELL overexpression mouse model |
| How does MIEF1 coordinate nuclear response to forces? | MIEF1 knockout and overexpression |
| What is the role of eEF1A1 in macrophage glycolysis? | eEF1A1 knockout macrophages |
| Does AFF4 mutation cause developmental defects? | AFF4 point mutation knock-in |
How to Study the transcription elongation factor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels | Global effects of elongation factor knockout |
| GRO-seq | Nascent transcription | Elongation rate and pausing |
| ChIP-seq | Factor occupancy on chromatin | Localization of elongation factors |
| Co-IP/MS | Protein-protein interactions | Identification of elongation complexes |
| Ubiquitination assay | Post-translational modifications | ELOF1-mediated RNA Pol II ubiquitylation |
| Live-cell imaging | Dynamic localization | Real-time rescue of stalled polymerases |
| CRISPR screen | Gene essentiality | Identification of elongation factor dependencies |
Transcriptional profiling
RNA-seq and nascent RNA sequencing (e.g., GRO-seq) can measure the impact of elongation factor perturbations on transcription genome-wide.
Protein interaction studies
Co-immunoprecipitation and mass spectrometry can identify complexes containing elongation factors and their substrates.
Ubiquitination assays
In vitro and in vivo ubiquitination assays can detect RNA polymerase II modifications directed by factors like ELOF1.
Imaging
Live-cell imaging of RNA polymerase II and elongation factors can reveal dynamics at stalled forks.
How CRISPR Can Be Used to Study GO:0003711 transcription elongation factor activity
Knockout
CRISPR knockout of elongation factor genes such as ELOF1 can reveal their essential roles in transcription-coupled repair and cell survival.
Point Mutation
Introducing point mutations in catalytic residues of CDK9 or TFIIS allows precise dissection of their elongation functions.
Knock-in
Knock-in of tagged versions of elongation factors (e.g., GFP-ELOF1) enables live-cell imaging and proteomic studies.
Overexpression
Overexpression of ELL or AFF1 can model leukemogenic fusion proteins and test oncogenic potential.
How EDITGENE Supports transcription elongation factor activity Research
Researchers studying transcription elongation factor activity-related genes often need to determine whether a candidate gene is causally involved in a specific transcriptional or disease phenotype. This requires precise genetic models that can isolate the function of individual elongation factors.
Contact EDITGENE today to design your custom CRISPR model for transcription elongation factor activity research.
Frequently Asked Questions About transcription elongation factor activity
What is transcription elongation factor activity?
It is a molecular function that stimulates the elongation properties of RNA polymerase during the elongation phase of transcription.
What genes are involved in transcription elongation factor activity?
Key genes include ELOF1, TFIIS, SPT5, SPT4, ELL, CDK9, and AFF4, among others.
What is the GO ID for transcription elongation factor activity?
The GO ID is GO:0003711.
How do transcription elongation factors work?
They enable the transition from initiation to elongation, rescue stalled RNA polymerases, and couple transcription to DNA repair.
What diseases are associated with transcription elongation factor activity?
Cancer, developmental disorders, and neurodegeneration have been linked to defects in elongation factors.
What experimental models are used to study transcription elongation factor activity?
CRISPR knockout, point mutation, knock-in, and overexpression cell lines are commonly used.
How can I study transcription elongation factor activity in my lab?
You can use RNA-seq, ChIP-seq, ubiquitination assays, and live-cell imaging, often combined with CRISPR models.
What is the role of ELOF1 in transcription elongation?
ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation.
Can transcription elongation factors be targeted for cancer therapy?
Yes, CDK9 inhibitors are in clinical trials for cancer, and other elongation factors are being explored as targets.
What services does EDITGENE offer for transcription elongation factor research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics support.
Conclusion
Transcription elongation factor activity (GO:0003711) is a fundamental molecular function that controls the processivity of RNA polymerase and couples transcription to DNA repair and other cellular processes. Its dysregulation is implicated in cancer, developmental disorders, and neurodegeneration, making it a promising therapeutic target. Advances in CRISPR-based models and functional genomics are accelerating our understanding of these factors and their roles in health and disease.
References
- 1. Goodson JR et al.. 2018. Processive Antitermination.. Microbiol Spectr 6(5) PMID: 30191803
- 2. Romani P et al.. 2022. Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.. Nat Cell Biol 24(2):168-180 PMID: 35165418
- 3. Romani P et al.. 2024. Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces.. Nat Cell Biol 26(12):2046-2060 PMID: 39433949
- 5. van der Weegen Y et al.. 2021. ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation.. Nat Cell Biol 23(6):595-607 PMID: 34108663
- 6. Conaway JW et al.. 1999. Transcription elongation and human disease.. Annu Rev Biochem 68:301-19 PMID: 10872452
- 7. Xie B et al.. 2025. Disruption of the eEF1A1/ARID3A/PKC-δ Complex by Neferine Inhibits Macrophage Glycolytic Reprogramming in Atherosclerosis.. Adv Sci (Weinh) 12(15):e2416158 PMID: 39973763
